BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for NLS Pharmaceutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-16 4:45 pm Purchase | 2022-12-06 | 13G | NLS Pharmaceutics AG NLSP | BIOTECHNOLOGY VALUE FUND L P | 171,479 19.990% | 171,479 (New Position) | Filing |